More black men to benefit from prostate cancer screening trial
The UK government is investing £18 million into a prostate cancer screening trial specifically targeting black men, who face a significantly higher risk of the disease. The trial aims to determine if advanced testing methods like MRI scans and genetic checks are more effective than standard PSA tests.
Why it matters
Addressing health disparities in cancer screening is critical for improving survival rates among high-risk demographics and refining national health policy.
Image source, Getty Images By Philippa Roxby Health reporter Published 2 June 2026 Tens of thousands more black men aged 45-74 are to be invited for prostate cancer checks as part of an ongoing trial in the UK to find better ways of testing for the disease.
The article reports on government policy and medical research findings in a factual, objective manner.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in